Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

[Talking about home hospices with terminally ill cancer patients -- a multicenter survey of bereaved families].

Yamagishi A, Morita T, Kawagoe S, Shimizu M, Ozawa T, An E, Kobayakawa M, Tsuneto S, Shima Y, Miyashita M.

Gan To Kagaku Ryoho. 2015 Mar;42(3):327-33. Japanese.

PMID:
25812502
2.

[The cutting-edge of medicine; current status and issues of home medical care].

Kawagoe S.

Nihon Naika Gakkai Zasshi. 2014 Dec 10;103(12):3106-17. Review. Japanese. No abstract available.

PMID:
25812344
3.

Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.

Miura T, Matsumoto Y, Hama T, Amano K, Tei Y, Kikuchi A, Suga A, Hisanaga T, Ishihara T, Abe M, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Morita T, Kinoshita H.

Support Care Cancer. 2015 Mar 17. [Epub ahead of print]

PMID:
25777319
4.

Questionnaire survey on current status of home care and support for patients with hematological diseases.

Adachi A, Tsukada Y, Kondo S, Asakura K, Matsuki E, Kawagoe S, Hashiguchi S, Nonaka H, Takeda J, Okamoto S.

Rinsho Ketsueki. 2014 Nov;55(11):2262-70.

PMID:
25501405
5.

Independent validation of the modified prognosis palliative care study predictor models in three palliative care settings.

Baba M, Maeda I, Morita T, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Ono S, Ozawa T, Yamamoto R, Tsuneto S.

J Pain Symptom Manage. 2015 May;49(5):853-60. doi: 10.1016/j.jpainsymman.2014.10.010. Epub 2014 Dec 12.

PMID:
25499420
6.

Length of home hospice care, family-perceived timing of referrals, perceived quality of care, and quality of death and dying in terminally ill cancer patients who died at home.

Yamagishi A, Morita T, Kawagoe S, Shimizu M, Ozawa T, An E, Kobayakawa M, Tsuneto S, Shima Y, Miyashita M.

Support Care Cancer. 2015 Feb;23(2):491-9. doi: 10.1007/s00520-014-2397-7. Epub 2014 Aug 21.

PMID:
25142705
7.

The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.

Higuchi T, Kawagoe S, Otsu M, Shimada Y, Kobayashi H, Hirayama R, Eto K, Ida H, Ohashi T, Nakauchi H, Eto Y.

Mol Genet Metab. 2014 May;112(1):44-8. doi: 10.1016/j.ymgme.2014.02.012. Epub 2014 Mar 4.

PMID:
24642446
8.

Performance of severity scores for home care-based patients suffering from pneumonia.

Ishibashi F, Sunohara M, Kawagoe S.

Geriatr Gerontol Int. 2015 Mar;15(3):311-7. doi: 10.1111/ggi.12274. Epub 2014 Mar 12.

PMID:
24617550
9.

[Home care medicine for terminally ill patients].

Kawagoe S.

Rinsho Shinkeigaku. 2013;23(11):1295. Japanese. No abstract available.

PMID:
24291965
10.

Exploring the perceived changes and the reasons why expected outcomes were not obtained in individual levels in a successful regional palliative care intervention trial: an analysis for interpretations.

Morita T, Sato K, Miyashita M, Akiyama M, Kato M, Kawagoe S, Kinoshita H, Shirahige Y, Yamakawa S, Yamada M, Eguchi K.

Support Care Cancer. 2013 Dec;21(12):3393-402. doi: 10.1007/s00520-013-1910-8. Epub 2013 Aug 10.

PMID:
23934223
11.

Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp).

Kawagoe S, Higuchi T, Otaka M, Shimada Y, Kobayashi H, Ida H, Ohashi T, Okano HJ, Nakanishi M, Eto Y.

Mol Genet Metab. 2013 Aug;109(4):386-9. doi: 10.1016/j.ymgme.2013.06.003. Epub 2013 Jun 12.

PMID:
23810832
12.

Bond strength to radicular dentin and sealing ability of AH Plus in combination with a bonding agent.

Andrade-Júnior CV, Kawagoe ST, Almeida JF, Gomes BP, Zaia AA, Ferraz CC.

Acta Odontol Scand. 2013 Sep;71(5):1200-5. doi: 10.3109/00016357.2012.757363. Epub 2013 May 16.

PMID:
23675694
13.

Study on the factors determining home death of patients during home care: a historical cohort study at a home care support clinic.

Kawagoe S, Tsuda T, Doi H.

Geriatr Gerontol Int. 2013 Oct;13(4):874-80. doi: 10.1111/ggi.12018. Epub 2012 Dec 26.

PMID:
23279052
14.

[Development of a home care educational program for community physicians and other professionals-a trial in Kashiwa City].

Yoshie S, Nishinaga M, Kawagoe S, Hirahara S, Fujita S, Irahara M, Anzai Y, Onozawa S, Oishi Y, Suzuki H, Numata M, Katayama F, Murayama H, Tsuchiya R, Kimata M, Shibasaki K, Iijima K, Tsuji T.

Gan To Kagaku Ryoho. 2012 Dec;39 Suppl 1:80-5. Japanese.

PMID:
23268908
15.

Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.

Higuchi T, Shimizu H, Fukuda T, Kawagoe S, Matsumoto J, Shimada Y, Kobayashi H, Ida H, Ohashi T, Morimoto H, Hirato T, Nishino K, Eto Y.

Mol Genet Metab. 2012 Sep;107(1-2):122-8. doi: 10.1016/j.ymgme.2012.05.005. Epub 2012 May 18.

PMID:
22704483
16.

Patient-perceived usefulness and practical obstacles of patient-held records for cancer patients in Japan: OPTIM study.

Komura K, Yamagishi A, Akizuki N, Kawagoe S, Kato M, Morita T, Eguchi K.

Palliat Med. 2013 Feb;27(2):179-84. doi: 10.1177/0269216311431758. Epub 2011 Dec 16.

PMID:
22179597
17.

Age, gender, will, and use of home-visit nursing care are critical factors in home care for malignant diseases; a retrospective study involving 346 patients in Japan.

Kodama Y, Matsumura T, Yamaguchi T, Takita M, Kawagoe S, Kimura Y, Hirahara S, Suzuki H, Ohta H, Onozawa S, Wada T, Nakamura Y, Nakano K, Kami M, Yuji K.

BMC Palliat Care. 2011 Nov 1;10:17. doi: 10.1186/1472-684X-10-17.

18.

Endoplasmic reticulum stress induces autophagy through activation of p38 MAPK in fibroblasts from Pompe disease patients carrying c.546G>T mutation.

Shimada Y, Kobayashi H, Kawagoe S, Aoki K, Kaneshiro E, Shimizu H, Eto Y, Ida H, Ohashi T.

Mol Genet Metab. 2011 Dec;104(4):566-73. doi: 10.1016/j.ymgme.2011.09.005. Epub 2011 Sep 14.

PMID:
21982629
19.

Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells.

Kawagoe S, Higuchi T, Meng XL, Shimada Y, Shimizu H, Hirayama R, Fukuda T, Chang H, Nakahata T, Fukada S, Ida H, Kobayashi H, Ohashi T, Eto Y.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):123-8. doi: 10.1016/j.ymgme.2011.05.020. Epub 2011 Jun 2.

PMID:
21703893
20.

Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders.

Meng XL, Shen JS, Kawagoe S, Ohashi T, Brady RO, Eto Y.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7886-91. doi: 10.1073/pnas.1002758107. Epub 2010 Apr 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk